Linear alkylbenzene sulfonate (LAS) was administered subcutaneously to pregnant mice during the critical period of the organogenesis in the fetuses, and its embryotoxic and teratogenic effects were examined. LAS was given once daily at doses of 0.4, 2, 10 and 50 mg/kg for 7 days from day 7 to 13 of gestation. The results obtained were as follows. 1. No suppression of body weight gain of pregnant mice was seen in all groups, and the pregnancy was well maintained. Some weight changes in a few organs of dams were observed, but these changes were not dose-dependent, and also no significant pathological changes of the organs were found in any group. 2. Neither fetal mortality nor growth inhibition of live fetuses were noticed, and also no significant differences between the treated and control groups were found in external and internal anomalies of fetuses. In the examination for skeletal system of fetuses, a significant retarded ossification of calcaneus or talus in 10 mg/kg group and of talus in 2 mg/kg group were noticed. The groups given 0.4, 2 and 10 mg/kg LAS showed a higher incidence of fetuses with 14th rib than the control group, but no significant differences between the highest dose and the control groups were found. No skeletal anomalies were found in all groups. 3. In the postnatal observation, the mean litter size was lower in 0.4, 2 and 10 mg/kg groups than in the control, but the body weight gain of newborn after delivery in these groups was greater than in control. Among other groups except 0.4 mg/kg group, no marked differences in weaning rate at 3 weeks after birth were observed. No deleterious effects on postnatal differentiation and motor or sensory activities of newborn were observed in any group, and neither were there any fetuses found with external, internal or skeletal anomalies.
View full abstract